Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF SYDNEY

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Established: 1850-01-01

Employees: -

Market Cap: -

Website: https://www.sydney.edu.au/

Clinical Trials

Adaptive CT Acquisition for Personalised Thoracic Imaging

Completed

Conditions: Cancer, Lung

Interventions: Device: 4DCBCT images

First Posted Date: 2019-08-28

Last Posted Date: 2021-05-19

Lead Sponsor: University of Sydney

Target Recruit Count: 30

Registration Number: NCT04070586

Locations: 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia

A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

Phase 3

Recruiting

Conditions: Elevated IMR (>32)
STEMI

Interventions: Drug: Tenecteplase (1/3 systemic weight based dose)
Other: Sterile water for injection (WFI)

First Posted Date: 2019-06-26

Last Posted Date: 2023-10-30

Lead Sponsor: University of Sydney

Target Recruit Count: 445

Registration Number: NCT03998319

Locations: 🇦🇺
Victorian Heart Hospital, Clayton, Victoria, Australia
🇦🇺
Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

and more 19 locations

Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Phase 2

Active, not recruiting

Conditions: EGFR Mutant Advanced Non Small Cell Lung Cancer

Interventions: Drug: Tremelimumab
Drug: Durvalumab

First Posted Date: 2019-06-21

Last Posted Date: 2023-04-21

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT03994393

Locations: 🇦🇺
St George Hospital, Kogarah, New South Wales, Australia
🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺
The Prince Charles Hospital, Chermside, Queensland, Australia

and more 13 locations

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

Not Applicable

Completed

Conditions: Melanoma (Skin)

Interventions: Behavioral: Clinician-led surveillance
Device: Patient-led surveillance

First Posted Date: 2018-07-10

Last Posted Date: 2023-08-01

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT03581188

Locations: 🇦🇺
Newcastle Skin Check, Newcastle, New South Wales, Australia
🇦🇺
Melanoma Institute Australia, North Sydney, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Composition of Functional Tooth Units and Nutrient Intake in Older Men

Completed

Conditions: Dietary Assessment of Older Men
Oral Health of Older Men

First Posted Date: 2017-09-27

Last Posted Date: 2017-09-27

Lead Sponsor: University of Sydney

Target Recruit Count: 781

Registration Number: NCT03295435

Locations: 🇦🇺
The Centre for Education and Research on Ageing, Sydney, New South Wales, Australia

Evaluation of a Patient-Reported Symptom Index for NMIBC

Completed

Conditions: Superficial Bladder Cancer

First Posted Date: 2017-03-27

Last Posted Date: 2021-10-13

Lead Sponsor: University of Sydney

Target Recruit Count: 498

Registration Number: NCT03091764

Locations: 🇺🇸
University of Kansas, Kansas City, Kansas, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 16 locations

Prophylactic Early PN in HPT/BMT

Not Applicable

Conditions: Hematologic Neoplasms

Interventions: Dietary Supplement: Parenteral nutrition.
Other: Pragmatic standard care.

First Posted Date: 2017-03-20

Last Posted Date: 2021-04-28

Lead Sponsor: University of Sydney

Target Recruit Count: 408

Registration Number: NCT03083327

Locations: 🇦🇺
Royal North Shore Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇳🇿
Christchurch Hospital, CDHB, Christchurch, New Zealand

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns

Phase 3

Completed

Conditions: Hypoxic-Ischemic Encephalopathy

Interventions: Drug: Epoetin Alfa
Drug: Normal saline

First Posted Date: 2017-03-14

Last Posted Date: 2024-06-05

Lead Sponsor: University of Sydney

Target Recruit Count: 313

Registration Number: NCT03079167

Locations: 🇦🇺
Canberra Hospital, Garran, Australian Capital Territory, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia

and more 21 locations

Patient Experience and Acceptance of Horizontal Rotation

Not Applicable

Recruiting

Conditions: Cancer

Interventions: Device: Nano-X patient rotation

First Posted Date: 2016-12-16

Last Posted Date: 2024-07-03

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT02995603

Locations: 🇦🇺
Prince of Wales Hospital, Randwick, New South Wales, Australia

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

Not Applicable

Active, not recruiting

Conditions: Liver Cancer

Interventions: Device: Kilovoltage Intrafraction Monitoring

First Posted Date: 2016-12-07

Last Posted Date: 2025-04-04

Lead Sponsor: University of Sydney

Target Recruit Count: 32

Registration Number: NCT02984566

Locations: 🇦🇺
Nepean Hospital, Penrith, New South Wales, Australia
🇦🇺
Westmead Hospital, Westmead, New South Wales, Australia
🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy